Medication info
Olpat 20 mg (Atorvastatin Calcium Trihydrate)

Olpat 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet경구
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
아주약품(주)
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201307357 · Approved 2013.05.15 · Insurance code 654004310

Summary

Main use
Reduction of the risk of myocardial infarction and stroke, and improvement of hyperlipidemia
Who takes it
Adults · Children
Adult dose
For the treatment of hyperlipidemia, the recommended initial dose is 10 mg once daily, and if a greater reduction in LDL cholesterol is needed, it can be initiated at 20 mg or 40 mg once daily. Doses are administered within a range of 10–80 mg once daily. The dose should be individualized based on patient characteristics, and lipid levels should be analyzed within 2-4 weeks after initiation or dose adjustment to modify the dose according to responses. The treatment goal is to lower LDL cholesterol levels, so it is recommended to use LDL cholesterol levels for evaluation during treatment initiation and response assessment. However, if LDL cholesterol levels are not available, total cholesterol levels should be used to monitor treatment response. In patients with homozygous familial hypercholesterolemia, the administration range is 10–80 mg once daily, used in conjunction with other lipid-lowering therapies (e.g., LDL apheresis) or when such methods are not feasible. For pediatric patients (ages 10-17) with heterozygous familial hypercholesterolemia, the recommended initial dose is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there is no clinical data on dosages greater than 20 mg in this age group). The dosage should be adjusted appropriately according to therapeutic goals for individual patients at an interval of 4 weeks or more. ○ In patients with renal impairment: Kidney disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effects, so dosage adjustment is not necessary. ○ In the elderly: The effectiveness and safety of this drug in patients aged 70 and older are similar to those in the general adult population.
Child dose
The recommended initial dose for pediatric patients (ages 10-17) with heterozygous familial hypercholesterolemia is 10 mg once daily, and the maximum dose is 20 mg once daily. The dosage should be adjusted according to the therapeutic goals at intervals of at least 4 weeks.

Ingredients

Manufacturer
아주약품(주)

Efficacy & effects

Reduction of the risk of myocardial infarction and stroke, and improvement of hyperlipidemia

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hyperlipidemia
  • primary hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps to reduce the risk of cardiovascular diseases. Particularly, it lowers the risk of myocardial infarction and stroke in adults who have risk factors for coronary heart disease and in patients with type 2 diabetes, while also reducing the risk of vascular surgeries and angina. Furthermore, it improves cholesterol and triglyceride levels in patients with hyperlipidemia and raises HDL cholesterol levels. It is also used to lower total cholesterol and LDL cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. Overall, this medication is used to maintain cardiovascular health and effectively decrease the risk of related diseases.

How to take

Adult dose

For the treatment of hyperlipidemia, the recommended initial dose is 10 mg once daily, and if a greater reduction in LDL cholesterol is needed, it can be initiated at 20 mg or 40 mg once daily. Doses are administered within a range of 10–80 mg once daily. The dose should be individualized based on patient characteristics, and lipid levels should be analyzed within 2-4 weeks after initiation or dose adjustment to modify the dose according to responses. The treatment goal is to lower LDL cholesterol levels, so it is recommended to use LDL cholesterol levels for evaluation during treatment initiation and response assessment. However, if LDL cholesterol levels are not available, total cholesterol levels should be used to monitor treatment response. In patients with homozygous familial hypercholesterolemia, the administration range is 10–80 mg once daily, used in conjunction with other lipid-lowering therapies (e.g., LDL apheresis) or when such methods are not feasible. For pediatric patients (ages 10-17) with heterozygous familial hypercholesterolemia, the recommended initial dose is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there is no clinical data on dosages greater than 20 mg in this age group). The dosage should be adjusted appropriately according to therapeutic goals for individual patients at an interval of 4 weeks or more. ○ In patients with renal impairment: Kidney disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effects, so dosage adjustment is not necessary. ○ In the elderly: The effectiveness and safety of this drug in patients aged 70 and older are similar to those in the general adult population.

Child dose

The recommended initial dose for pediatric patients (ages 10-17) with heterozygous familial hypercholesterolemia is 10 mg once daily, and the maximum dose is 20 mg once daily. The dosage should be adjusted according to the therapeutic goals at intervals of at least 4 weeks.

Precautions

This medication may cause muscle problems, so use should be stopped immediately if muscle pain or weakness occurs, or if muscle-related values are elevated in blood tests. This medication may affect liver function, so patients with liver disease or abnormally high liver enzyme levels should not take it. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. This medication should not be given to children under 10 years of age or those with certain genetic disorders. Patients with a history of alcohol abuse or liver disease, as well as those with impaired kidney function, should use this medication with caution and require regular monitoring. This medication may interact with other drugs, so it is essential to consult a doctor or pharmacist, especially when taking certain antibiotics, antifungals, or antivirals. Side effects such as muscle pain, cramps, weakness, insomnia, digestive disorders, headache, rash, etc. may occur, and if any unusual symptoms arise, medical personnel should be informed immediately. While taking this medication, regular blood tests and liver function tests should be performed, and if any abnormal findings appear, discontinuation of the medication should occur. There is no specific antidote for overdose, so treatment and examination according to symptoms are necessary. Keep this medication out of the reach of children and store it in its original container. Proper contraceptive methods should be utilized while taking this medication, and if pregnancy is confirmed, use should be discontinued immediately.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/visual mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe lethargy, liver issues (jaundice), sudden and very severe headache, thunderclap headache, pain

Mild side effects

  • Weakness
  • fatigue
  • chest pain
  • peripheral edema
  • tiredness
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 27 more
  • anorexia
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pain in the throat/larynx
  • nosebleeds
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbances
  • memory loss
  • peripheral neuropathy
  • muscle pain
  • joint pain
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to ensure the medication's effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.